Drug Profile
Diclofenac - LTT Bio-Pharma
Alternative Names: Diclofenac sodium eye-drops - LTT Bio-Pharma; LT 0303; LT 4002Latest Information Update: 17 Dec 2021
Price :
$50
*
At a glance
- Originator LTT Bio-Pharma
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Dry eyes
Most Recent Events
- 08 Oct 2021 Phase II development is ongoing in Japan (LTT Bio-Pharma pipeline, October,
- 31 Mar 2020 LTT Bio-Pharma completes a phase II trial in Dry eyes in Japan (UMIN000036467)
- 11 Apr 2019 LTT Bio-Pharma initiates enrolment in a phase II trial for Dry eyes in Japan (Ophthalmic) (UMIN000036467)